scholarly article | Q13442814 |
P2093 | author name string | Inderjit Singh | |
Avtar K Singh | |||
Ernest Barbosa | |||
Ravinder Pannu | |||
P2860 | cites work | Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy | Q40602065 |
Chronic relapsing experimental allergic encephalomyelitis: clinicopathological comparison with multiple sclerosis | Q46633710 | ||
P433 | issue | 3 | |
P921 | main subject | inflammation | Q101991 |
P304 | page(s) | 340-350 | |
P577 | publication date | 2005-02-01 | |
P1433 | published in | Journal of Neuroscience Research | Q6295654 |
P1476 | title | Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in rats | |
P478 | volume | 79 |
Q42914601 | A Quadruped Study on Chitosan Microspheres Containing Atorvastatin Calcium: Preparation, Characterization, Quantification and <i>in-Vivo</i> Application |
Q52720025 | A Single Dose of Atorvastatin Applied Acutely after Spinal Cord Injury Suppresses Inflammation, Apoptosis, and Promotes Axon Outgrowth, Which Might Be Essential for Favorable Functional Outcome. |
Q35127468 | A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury |
Q42276078 | Acute injury in the peripheral nervous system triggers an alternative macrophage response. |
Q36092501 | An overview of pharmacological approaches for management and repair of spinal cord injuries |
Q52650373 | Anti-apoptotic and anti-oxidative roles of quercetin after traumatic brain injury. |
Q50481450 | Aquaporin-4 mitigates retrograde degeneration of rubrospinal neurons by facilitating edema clearance and glial scar formation after spinal cord injury in mice. |
Q43239618 | Atorvastatin treatment attenuates motor neuron degeneration in wobbler mice |
Q34430212 | Attenuation of astrogliosis and modulation of endothelial growth factor receptor in lipid rafts by simvastatin after traumatic brain injury |
Q37822693 | Chemical priming for spinal cord injury: a review of the literature part II-potential therapeutics |
Q26824854 | Current and future medical therapeutic strategies for the functional repair of spinal cord injury |
Q48554189 | Decreased GFAP expression and improved functional recovery in contused spinal cord of rats following valproic acid therapy. |
Q37337494 | Differential effects of simvastatin and pravastatin on expression of Alzheimer's disease-related genes in human astrocytes and neuronal cells |
Q38602852 | Effect of chondroitinase ABC on inflammatory and oxidative response following spinal cord injury |
Q47096024 | Effects of Atorvastatin in Patients with Acute Spinal Cord Injury |
Q39918468 | FTY720 reduces inflammation and promotes functional recovery after spinal cord injury |
Q35015086 | Hyperlipidemia and statins affect neurological outcome in lumbar spine injury |
Q42913908 | Improved outcome of EAN, an animal model of GBS, through amelioration of peripheral and central inflammation by minocycline |
Q38677461 | Increased risk of anxiety or depression after traumatic spinal cord injury in patients with pre-existing hyperlipidemia: a population-based study |
Q35993239 | Inflammation & apoptosis in spinal cord injury |
Q34132516 | Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury. |
Q34685463 | Molecular mechanisms underlying the effects of statins in the central nervous system |
Q35029109 | Neuroprotective effect of atorvastatin in spinal cord ischemia-reperfusion injury |
Q30385195 | Neuroprotective effects of atomoxetine against traumatic spinal cord injury in rats. |
Q36428437 | Neuroprotective therapy using granulocyte colony-stimulating factor for acute spinal cord injury: a phase I/IIa clinical trial |
Q36953948 | Plasmalogen deficiency in cerebral adrenoleukodystrophy and its modulation by lovastatin |
Q28570210 | Sex differences and effects of estrogenic compounds on the expression of inflammatory molecules by astrocytes exposed to the insecticide dimethoate |
Q36654856 | Simvastatin ameliorates cauda equina compression injury in a rat model of lumbar spinal stenosis. |
Q37358933 | Simvastatin attenuates microglial cells and astrocyte activation and decreases interleukin-1beta level after traumatic brain injury |
Q33864425 | Simvastatin protects bladder and renal functions following spinal cord injury in rats. |
Q37671313 | Simvastatin protects ischemic spinal cord injury from cell death and cytotoxicity through decreasing oxidative stress: in vitro primary cultured rat spinal cord model under oxygen and glucose deprivation-reoxygenation conditions |
Q39654188 | Simvastatin treatment improves functional recovery after experimental spinal cord injury by upregulating the expression of BDNF and GDNF |
Q79756806 | Spatiotemporal alterations of the NO/NOS neuronal pools following transient abdominal aorta occlusion: morphological and biochemical studies in the rabbit |
Q35216123 | Statin-induced T-lymphocyte modulation and neuroprotection following experimental subarachnoid hemorrhage |
Q37119244 | Statins in the spectrum of neurologic disease |
Q37676004 | Strategies for protecting oligodendrocytes and enhancing remyelination in multiple sclerosis |
Q48761733 | Systemic inflammation induces axon injury during brain inflammation. |
Q53076892 | The attenuation of neurological injury from the use of simvastatin after spinal cord ischemia-reperfusion injury in rats. |
Q36041142 | The neuroprotective effect of treatment of valproic Acid in acute spinal cord injury |
Q37739315 | The role of statins in neurosurgery |